BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will highlight the integral role it is playing in liquid biopsy research at the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo.
Experts Keeping Close Eye on BA.2.86 Variant
With more than 30 mutations, BA.2.86 is capturing the attention of public health experts around the world, including the CDC, which issued a risk assessment
August 24, 2023